Status
Terminated
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Status
Terminated
Classification
Class I
Report Date
March 8, 2023
Termination Date
August 20, 2024